Position in GILD
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$44,249,321
-$4,173,252 QoQ
Shares Held
350,240
+0.8% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
4.09%
of 13F equity value
Holder Rank
#227
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ATWOOD & PALMER INC holds $103,508,444 across 10 Drug Manufacturers - General names. GILD ranks #2 (42.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
195,763 | $49,261,801 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
350,240 | $44,249,321 | |
| 3 | JNJ |
Johnson & Johnson
|
24,671 | $6,265,693 | |
| 4 | AMGN |
Amgen Inc
|
5,540 | $2,006,144 | |
| 5 | LLY |
ELI LILLY & Co
|
568 | $681,276 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
11,728 | $675,767 | |
| 7 | PFE |
Pfizer Inc
|
9,929 | $239,090 | |
| 8 | MRK |
Merck & Co., Inc.
|
849 | $109,096 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,249,321 | 350,240 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $48,422,573 | 347,439 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $42,938,747 | 349,835 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $38,200,650 | 344,150 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $38,148,371 | 344,082 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $38,664,757 | 345,067 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $32,260,776 | 349,256 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $29,065,651 | 346,680 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $23,735,217 | 345,944 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $25,402,660 | 346,794 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $27,415,323 | 338,419 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $25,325,523 | 337,944 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $25,953,245 | 336,749 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $20,515,991 | 247,270 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $21,207,182 | 247,026 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $14,968,214 | 242,636 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $14,657,005 | 237,130 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $13,836,571 | 232,743 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $16,565,100 | 228,138 | Shares | Sole | 2022-01-24 | |
| 2021-06-30 | $14,780,248 | 214,642 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $13,462,687 | 208,304 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $12,060,460 | 207,011 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $12,961,153 | 205,114 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $15,813,939 | 205,536 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $15,625,512 | 209,009 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||